News Focus
News Focus
Followers 22
Posts 4664
Boards Moderated 0
Alias Born 01/27/2022

Re: Whalatane post# 375574

Tuesday, 04/26/2022 2:29:10 PM

Tuesday, April 26, 2022 2:29:10 PM

Post# of 447510

Oh come on Margin requirements for one thing are far more restrictive now then in 1929
Spreading fear FFS ?…. I’ll have to keep buying .
Bt yesterday at $2.94
If AMRN tests the PPS pts you posted today I’ll buy more
Kiwi



Not to mention, at AMRN's market cap, any time the price goes much lower, there are so many bottom dwellers (meant in an affectionate way!) willing to buy that value.

It's not like we're talking about a trillion dollar company that's overvalued like Tesla. We're talking about a company that is UNDERvalued, and barely scraping $1B (LESS, if you factor CoH). That's loose change for some institutions, which is one reason I can't wrap my head around why there have not been more institutional buyers at these prices. Maybe the Street just lost interest because it's evolving too slow, or went full stop at seeing "...lost U.S. patents" headlines all over the place. It's definitely a head scratcher.

But when you really dig in, the risk/reward ratio on AMRN is wildly in favor of investment. This is why I stay in it, despite my "devil's advocate" stance sometimes. I just feel like there is a floor in this stock because it's a proven, legitimate drug that is already actively being marketed and sold (OK, with "air quotes" around "marketed" )

But despite there being (what I believe) to be a solid floor, the potential upside is relatively uncapped, depending on how this plays out. So I feel like I could make a little, or a LOT, with very little downside (from HERE).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News